Found 13 with Last Name = 'sakamoto' and Initial = 'ji' 
Affinity DataIC50: 1nMAssay Description:Inhibition of C-terminal biotin-labelled BCoR (Arg498 to 514Pro residues) binding to recombinant FLAG-tagged BCL6 BTB (5 to 129 residues) (unknown or...More data for this Ligand-Target Pair
Affinity DataIC50: 2.12E+5nMAssay Description:Inhibition of C-terminal biotin-labelled BCoR/wild-type BCL6 BTB domain (unknown origin) protein-protein interaction by ELISAMore data for this Ligand-Target Pair
TargetGTPase KRas(Homo sapiens (Human))
Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan.
Curated by ChEMBL
Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan.
Curated by ChEMBL
Affinity DataKd: 35nMAssay Description:Binding affinity to human N-terminal His/AVi-tagged biotinylated GTPase KRas G12C mutant expressed in Escherichia coli BL21 (DE3) in presence of GDP ...More data for this Ligand-Target Pair
TargetGTPase KRas(Homo sapiens (Human))
Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan.
Curated by ChEMBL
Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan.
Curated by ChEMBL
Affinity DataKd: 250nMAssay Description:Binding affinity to human N-terminal His/AVi-tagged biotinylated GTPase KRas G12C mutant expressed in Escherichia coli BL21 (DE3) in presence of GTP ...More data for this Ligand-Target Pair
TargetGTPase KRas(Homo sapiens (Human))
Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan.
Curated by ChEMBL
Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan.
Curated by ChEMBL
Affinity DataKd: 200nMAssay Description:Binding affinity to human wild type N-terminal His/AVi-tagged biotinylated KRas expressed in Escherichia coli BL21 (DE3) in presence of GTP by SPR as...More data for this Ligand-Target Pair
TargetGTPase KRas(Homo sapiens (Human))
Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan.
Curated by ChEMBL
Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan.
Curated by ChEMBL
Affinity DataKd: 58nMAssay Description:Binding affinity to human wild type N-terminal His/AVi-tagged biotinylated KRas expressed in Escherichia coli BL21 (DE3) in presence of GDP by SPR as...More data for this Ligand-Target Pair
Affinity DataKd: 0.570nMAssay Description:Binding affinity to biotinylated BCL6 (unknown origin) by SPR analysisMore data for this Ligand-Target Pair
Affinity DataKd: 5.00E+3nMAssay Description:Binding affinity to wild-type avi-tagged BCL6 BTB domain (unknown origin) by SPR analysisMore data for this Ligand-Target Pair
3D Structure (crystal)
Affinity DataKd: 7.00E+3nMAssay Description:Binding affinity to recombinant RED-NHS labelled BCL6 BTB domain (1 to 129 residues) (unknown origin) after 10 mins by microscale thermophoresis meth...More data for this Ligand-Target Pair
Affinity DataKd: 1.29E+5nMAssay Description:Binding affinity to recombinant RED-NHS labelled BCL6 BTB domain (1 to 129 residues) (unknown origin) after 10 mins by microscale thermophoresis meth...More data for this Ligand-Target Pair
TargetGTPase KRas(Homo sapiens (Human))
Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan.
Curated by ChEMBL
Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan.
Curated by ChEMBL
Affinity DataKd: 11nMAssay Description:Binding affinity to human N-terminal His/AVi-tagged biotinylated GTPase KRas G12D mutant (1 to 169 residues) expressed in Escherichia coli BL21 (DE3)...More data for this Ligand-Target Pair
TargetGTPase KRas(Homo sapiens (Human))
Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan.
Curated by ChEMBL
Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan.
Curated by ChEMBL
Affinity DataKd: 200nMAssay Description:Binding affinity to human wild type N-terminal His/AVi-tagged biotinylated KRas expressed in Escherichia coli BL21 (DE3) in presence of GTP by SPR as...More data for this Ligand-Target Pair
Affinity DataKd: 2.40E+4nMAssay Description:Binding affinity to wild-type avi-tagged BCL6 BTB domain (unknown origin) by SPR analysisMore data for this Ligand-Target Pair
